-

Salesforce’s Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globally, fostering stronger relationships with healthcare professionals (HCPs) through data-driven, AI-powered engagement. This work will support AstraZeneca's commitment to push the boundaries of science to deliver life-changing medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology.

With Agentforce Life Sciences, Salesforce aims to help AstraZeneca unlock a new era of intelligent engagement — redefining customer relationships and accelerating business growth. The partnership will enable teams to focus on strategic customer outcomes and meaningful customer interactions.

Expanding its remit for AstraZeneca, Salesforce will support Agentforce 360 for Life Sciences as the global, end-to-end engagement solution for AstraZeneca, including:

  • Medical-Commercial Coordination: Consolidating healthcare professional (HCP) insights and surface context across teams.
  • Personalized Engagement: Scaling operations across key account, reimbursement, and field teams with next-best action recommendations. AstraZeneca will also orchestrate and automate digital campaigns across multiple channels based on customer preferences.
  • Model Context Protocol (MCP) Interoperability: Extending its composable architecture with Salesforce’s Agent Fabric, AstraZeneca will orchestrate internal and external agent actions across field engagement, commercial operations, and different brands and regions, allowing its care teams and AI agents to work seamlessly together.

“This partnership with AstraZeneca represents a clear step towards building intelligent, agentic customer engagement in the life sciences industry with their selection of Agentforce Life Sciences for Customer Engagement,” said Frank Defesche, SVP and GM of Life Sciences at Salesforce. “Together, we will empower AstraZeneca’s teams with the latest technology to deliver personalized engagement and accelerate the delivery of life-changing medicines to patients around the world.”

Learn more:

About Salesforce

Salesforce helps organizations of any size become Agentic Enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.com for more information.

Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.

Contacts

Maha Neouchy
Salesforce
Public Relations
408-568-8442
pr@salesforce.com

Salesforce

NYSE:CRM

Release Versions

Contacts

Maha Neouchy
Salesforce
Public Relations
408-568-8442
pr@salesforce.com

More News From Salesforce

DeVry University Transforms Adult Learner Support with Agentforce 360

SAN FRANCISCO & LISLE, Ill.--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 CRM, today announced the deployment of Agentforce 360 at DeVry University, marking the next phase in their 15-year relationship and supporting DeVry's evolution into an Agentic Enterprise. This deployment also marks a significant expansion of DeVry's existing multi-year AI strategy and its mission of bridging the gap between emerging technology and workforce readiness. DeVry University, a higher education insti...

Salesforce Data: AI and Agents Propel Cyber Week to Record $336.6B in Global Spend

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today unveiled its 2025 Cyber Week results (November 25–December 1), analyzing shopping data from over 1.5 billion shoppers. This was another record-breaking shopping week, with overall industry global sales increasing 7% year over year (YOY) to $336.6 billion, and U.S. sales accounting for $79.6 billion (up 5% YOY). These results signal a strong consumer appetite for buying this holiday season despite increasing glo...

Salesforce Announces Quarterly Dividend

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that its board of directors declared a quarterly cash dividend of $0.416 per share. The dividend is payable January 8, 2026 to shareholders of record on December 18, 2025. About Salesforce Salesforce helps organizations of any size become agentic enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.c...
Back to Newsroom